Hardware, Equipment & Parts
Build Your Comparison
Side-by-side financial analysisStock Comparison
ALNT vs EMR vs KO vs ROK vs AME
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Beverages - Non-Alcoholic
Industrial - Machinery
Industrial - Machinery
ALNT vs EMR vs KO vs ROK vs AME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Industrial - Machinery | Beverages - Non-Alcoholic | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $1.55B | $80.13B | $355.61B | $51.61B | $52.03B |
| Revenue (TTM) | $561M | $18.32B | $49.28B | $8.80B | $7.60B |
| Net Income (TTM) | $24M | $2.44B | $13.70B | $1.09B | $1.53B |
| Gross Margin | 31.2% | 52.7% | 61.7% | 52.5% | 36.6% |
| Operating Margin | 8.4% | 19.8% | 29.3% | 19.1% | 26.2% |
| Forward P/E | 36.2x | 22.0x | 25.3x | 35.5x | 27.9x |
| Total Debt | $197M | $13.76B | $45.49B | $3.65B | $2.28B |
| Cash & Equiv. | $41M | $1.54B | $10.27B | $468M | $458M |
ALNT vs EMR vs KO vs ROK vs AME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Allient Inc. (ALNT) | 100 | 258.8 | +158.8% |
| Emerson Electric Co. (EMR) | 100 | 230.6 | +130.6% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
| Rockwell Automation… (ROK) | 100 | 215.7 | +115.7% |
| AMETEK, Inc. (AME) | 100 | 254.1 | +154.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALNT vs EMR vs KO vs ROK vs AME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALNT ranks third and is worth considering specifically for growth exposure.
- Rev growth 4.6%, EPS growth 67.1%, 3Y rev CAGR 3.3%
- +166.9% vs EMR's +14.6%
EMR is the clearest fit if your priority is income & stability.
- Dividend streak 54 yrs, beta 1.61, yield 1.5%
- Lower P/E (22.0x vs 27.9x)
KO carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 2.26 vs ALNT's 5.32
- 27.8% margin vs ALNT's 4.3%
- 2.5% yield, 56-year raise streak, vs AME's 0.5%
- 13.1% ROA vs ALNT's 4.1%, ROIC 15.8% vs 7.7%
ROK is the clearest fit if your priority is defensive.
- Beta 1.52, yield 1.1%, current ratio 1.14x
AME is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 397.2% 10Y total return vs ROK's 333.4%
- Lower volatility, beta 0.93, Low D/E 21.5%, current ratio 1.06x
- 6.6% revenue growth vs ROK's 1.0%
- Beta 0.93 vs ALNT's 2.10, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.6% revenue growth vs ROK's 1.0% | |
| Value | Lower P/E (22.0x vs 27.9x) | |
| Quality / Margins | 27.8% margin vs ALNT's 4.3% | |
| Stability / Safety | Beta 0.93 vs ALNT's 2.10, lower leverage | |
| Dividends | 2.5% yield, 56-year raise streak, vs AME's 0.5% | |
| Momentum (1Y) | +166.9% vs EMR's +14.6% | |
| Efficiency (ROA) | 13.1% ROA vs ALNT's 4.1%, ROIC 15.8% vs 7.7% |
ALNT vs EMR vs KO vs ROK vs AME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ALNT vs EMR vs KO vs ROK vs AME — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 4 of 6 categories
EMR leads 1 • ALNT leads 1 • ROK leads 0 • AME leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KO is the larger business by revenue, generating $49.3B annually — 87.9x ALNT's $561M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to ALNT's 4.3%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $561M | $18.3B | $49.3B | $8.8B | $7.6B |
| EBITDAEarnings before interest/tax | $72M | $4.7B | $15.5B | $1.9B | $2.3B |
| Net IncomeAfter-tax profit | $24M | $2.4B | $13.7B | $1.1B | $1.5B |
| Free Cash FlowCash after capex | $41M | $3.1B | $12.6B | $1.3B | $1.7B |
| Gross MarginGross profit ÷ Revenue | +31.2% | +52.7% | +61.7% | +52.5% | +36.6% |
| Operating MarginEBIT ÷ Revenue | +8.4% | +19.8% | +29.3% | +19.1% | +26.2% |
| Net MarginNet income ÷ Revenue | +4.3% | +13.3% | +27.8% | +12.4% | +20.1% |
| FCF MarginFCF ÷ Revenue | +7.3% | +17.0% | +25.5% | +15.2% | +22.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.6% | +2.9% | +12.1% | +11.8% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +52.4% | +28.2% | +18.2% | +39.6% | +14.5% |
Valuation Metrics
EMR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 27.2x trailing earnings, KO trades at a 61% valuation discount to ALNT's 69.2x P/E. Adjusting for growth (PEG ratio), KO offers better value at 2.43x vs ALNT's 10.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $80.1B | $355.6B | $51.6B | $52.0B |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $92.3B | $390.8B | $54.8B | $53.9B |
| Trailing P/EPrice ÷ TTM EPS | 69.22x | 35.41x | 27.18x | 59.89x | 35.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 36.19x | 21.99x | 25.27x | 35.52x | 27.90x |
| PEG RatioP/E ÷ EPS growth rate | 10.18x | 7.84x | 2.43x | — | 3.18x |
| EV / EBITDAEnterprise value multiple | 23.27x | 18.29x | 26.39x | 31.34x | 28.65x |
| Price / SalesMarket cap ÷ Revenue | 2.80x | 4.45x | 7.42x | 6.19x | 7.03x |
| Price / BookPrice ÷ Book value/share | 5.07x | 3.99x | 10.40x | 14.00x | 4.94x |
| Price / FCFMarket cap ÷ FCF | 31.26x | 30.05x | 67.15x | 38.00x | 31.12x |
Profitability & Efficiency
KO leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $8 for ALNT. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs ALNT's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.0% | +12.1% | +41.1% | +29.6% | +14.4% |
| ROA (TTM)Return on assets | +4.1% | +5.8% | +13.1% | +9.7% | +9.6% |
| ROICReturn on invested capital | +7.7% | +8.2% | +15.8% | +15.1% | +12.1% |
| ROCEReturn on capital employed | +9.4% | +10.0% | +17.3% | +18.5% | +15.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 7 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.65x | 0.68x | 1.33x | 0.98x | 0.21x |
| Net DebtTotal debt minus cash | $156M | $12.2B | $35.2B | $3.2B | $1.8B |
| Cash & Equiv.Liquid assets | $41M | $1.5B | $10.3B | $468M | $458M |
| Total DebtShort + long-term debt | $197M | $13.8B | $45.5B | $3.6B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.31x | 6.46x | 10.70x | 9.06x | 23.34x |
Total Returns (Dividends Reinvested)
ALNT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALNT five years ago would be worth $25,019 today (with dividends reinvested), compared to $15,772 for EMR. Over the past 12 months, ALNT leads with a +166.9% total return vs EMR's +14.6%. The 3-year compound annual growth rate (CAGR) favors ALNT at 33.3% vs KO's 13.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +64.5% | +6.2% | +20.3% | +15.9% | +8.8% |
| 1-Year ReturnPast 12 months | +166.9% | +14.6% | +17.2% | +43.0% | +26.9% |
| 3-Year ReturnCumulative with dividends | +136.9% | +77.8% | +47.0% | +53.3% | +52.3% |
| 5-Year ReturnCumulative with dividends | +150.2% | +57.7% | +65.6% | +71.8% | +70.4% |
| 10-Year ReturnCumulative with dividends | +314.8% | +216.5% | +121.1% | +333.4% | +397.2% |
| CAGR (3Y)Annualised 3-year return | +33.3% | +21.1% | +13.7% | +15.3% | +15.1% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than ALNT's 2.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs EMR's 86.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.10x | 1.61x | -0.20x | 1.52x | 0.93x |
| 52-Week HighHighest price in past year | $95.65 | $165.15 | $84.04 | $468.11 | $243.18 |
| 52-Week LowLowest price in past year | $33.02 | $122.64 | $65.35 | $305.44 | $174.43 |
| % of 52W HighCurrent price vs 52-week peak | +95.5% | +86.6% | +98.3% | +98.1% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 70.7 | 53.9 | 60.6 | 56.0 | 48.6 |
| Avg Volume (50D)Average daily shares traded | 217K | 2.5M | 12.7M | 623K | 1.0M |
Analyst Outlook
KO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALNT as "Buy", EMR as "Buy", KO as "Buy", ROK as "Hold", AME as "Buy". Consensus price targets imply 14.4% upside for EMR (target: $164) vs -15.9% for ALNT (target: $77). For income investors, KO offers the higher dividend yield at 2.46% vs ALNT's 0.13%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $76.80 | $163.62 | $86.13 | $468.63 | $248.50 |
| # AnalystsCovering analysts | 5 | 41 | 48 | 39 | 29 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +1.5% | +2.5% | +1.1% | +0.5% |
| Dividend StreakConsecutive years of raises | 0 | 54 | 56 | 16 | 6 |
| Dividend / ShareAnnual DPS | $0.12 | $2.10 | $2.04 | $5.23 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.6% | +0.2% | +0.8% | +0.8% |
KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 1 (Valuation Metrics).
ALNT vs EMR vs KO vs ROK vs AME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALNT or EMR or KO or ROK or AME a better buy right now?
For growth investors, AMETEK, Inc.
(AME) is the stronger pick with 6. 6% revenue growth year-over-year, versus 1. 0% for Rockwell Automation, Inc. (ROK). The Coca-Cola Company (KO) offers the better valuation at 27. 2x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate Allient Inc. (ALNT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALNT or EMR or KO or ROK or AME?
On trailing P/E, The Coca-Cola Company (KO) is the cheapest at 27.
2x versus Allient Inc. at 69. 2x. On forward P/E, Emerson Electric Co. is actually cheaper at 22. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Coca-Cola Company wins at 2. 26x versus Allient Inc. 's 5. 32x.
03Which is the better long-term investment — ALNT or EMR or KO or ROK or AME?
Over the past 5 years, Allient Inc.
(ALNT) delivered a total return of +150. 2%, compared to +57. 7% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: AME returned +397. 2% versus KO's +121. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALNT or EMR or KO or ROK or AME?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Allient Inc. 's 2. 10β — meaning ALNT is approximately -1147% more volatile than KO relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.
05Which is growing faster — ALNT or EMR or KO or ROK or AME?
By revenue growth (latest reported year), AMETEK, Inc.
(AME) is pulling ahead at 6. 6% versus 1. 0% for Rockwell Automation, Inc. (ROK). On earnings-per-share growth, the picture is similar: Allient Inc. grew EPS 67. 1% year-over-year, compared to -7. 4% for Rockwell Automation, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALNT or EMR or KO or ROK or AME?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus 4. 0% for Allient Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 8. 7% for ALNT. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALNT or EMR or KO or ROK or AME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Coca-Cola Company (KO) is the more undervalued stock at a PEG of 2. 26x versus Allient Inc. 's 5. 32x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 22. 0x forward P/E versus 36. 2x for Allient Inc. — 14. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 4% to $163. 62.
08Which pays a better dividend — ALNT or EMR or KO or ROK or AME?
All stocks in this comparison pay dividends.
The Coca-Cola Company (KO) offers the highest yield at 2. 5%, versus 0. 1% for Allient Inc. (ALNT).
09Is ALNT or EMR or KO or ROK or AME better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Allient Inc. (ALNT) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, ALNT: +314. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALNT and EMR and KO and ROK and AME?
These companies operate in different sectors (ALNT (Technology) and EMR (Industrials) and KO (Consumer Defensive) and ROK (Industrials) and AME (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
EMR, KO, ROK, AME pay a dividend while ALNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.